Difference between revisions of "About-cancer/treatment/drugs/pegfilgrastim"
(Marked this version for translation) |
|||
| Line 1: | Line 1: | ||
<languages/> | <languages/> | ||
<translate> | <translate> | ||
| − | == Pegfilgrastim == | + | == Pegfilgrastim == <!--T:1--> |
| + | <!--T:2--> | ||
This page contains brief information about pegfilgrastim and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials. | This page contains brief information about pegfilgrastim and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials. | ||
| + | <!--T:3--> | ||
'''US Brand Name(s)''' | '''US Brand Name(s)''' | ||
| + | <!--T:4--> | ||
Fulphila | Fulphila | ||
| + | <!--T:5--> | ||
Neulasta | Neulasta | ||
| + | <!--T:6--> | ||
'''FDA Approved''' | '''FDA Approved''' | ||
| + | <!--T:7--> | ||
Yes | Yes | ||
| + | <!--T:8--> | ||
FDA label information for this drug is available at DailyMed. | FDA label information for this drug is available at DailyMed. | ||
| + | <!--T:9--> | ||
'''Use in Cancer''' | '''Use in Cancer''' | ||
| + | <!--T:10--> | ||
Pegfilgrastim is approved to reduce the chance of infection in patients with: | Pegfilgrastim is approved to reduce the chance of infection in patients with: | ||
| + | <!--T:11--> | ||
*'''Neutropenia''' caused by myelosuppressive chemotherapy for certain types of cancer. | *'''Neutropenia''' caused by myelosuppressive chemotherapy for certain types of cancer. | ||
| + | <!--T:12--> | ||
Pegfilgastrim is a form of filgrastim that has polyethylene glycol (PEG) attached to it. This form stays in the body longer than does filgrastim, so it doesn’t need to be given as often. For more information about filgrastim, see the Drug Information Summary for Filgrastim. | Pegfilgastrim is a form of filgrastim that has polyethylene glycol (PEG) attached to it. This form stays in the body longer than does filgrastim, so it doesn’t need to be given as often. For more information about filgrastim, see the Drug Information Summary for Filgrastim. | ||
| + | <!--T:13--> | ||
'''More About Pegfilgrastim''' | '''More About Pegfilgrastim''' | ||
| + | <!--T:14--> | ||
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug. | Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug. | ||
| + | <!--T:15--> | ||
MedlinePlus Information on Pegfilgrastim - A lay language summary of important information about this drug that may include the following: | MedlinePlus Information on Pegfilgrastim - A lay language summary of important information about this drug that may include the following: | ||
| + | <!--T:16--> | ||
*warnings about this drug, | *warnings about this drug, | ||
| + | <!--T:17--> | ||
*what this drug is used for and how it is used, | *what this drug is used for and how it is used, | ||
| + | <!--T:18--> | ||
*what you should tell your doctor before using this drug, | *what you should tell your doctor before using this drug, | ||
| + | <!--T:19--> | ||
*what you should know about this drug before using it, | *what you should know about this drug before using it, | ||
| + | <!--T:20--> | ||
*other drugs that may interact with this drug, and | *other drugs that may interact with this drug, and | ||
| + | <!--T:21--> | ||
*possible side effects. | *possible side effects. | ||
| + | <!--T:22--> | ||
Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied. | Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied. | ||
| + | <!--T:23--> | ||
'''Research Results and Related Resources''' | '''Research Results and Related Resources''' | ||
| + | <!--T:24--> | ||
Immune System Modulators | Immune System Modulators | ||
| + | <!--T:25--> | ||
'''Clinical Trials Accepting Patients''' | '''Clinical Trials Accepting Patients''' | ||
| + | <!--T:26--> | ||
Find Clinical Trials for Pegfilgrastim - Check for trials from NCI's list of cancer clinical trials now accepting patients. | Find Clinical Trials for Pegfilgrastim - Check for trials from NCI's list of cancer clinical trials now accepting patients. | ||
| + | <!--T:27--> | ||
'''Important:''' The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug. | '''Important:''' The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug. | ||
</translate> | </translate> | ||
Latest revision as of 21:15, 29 October 2019
Pegfilgrastim
This page contains brief information about pegfilgrastim and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
US Brand Name(s)
Fulphila
Neulasta
FDA Approved
Yes
FDA label information for this drug is available at DailyMed.
Use in Cancer
Pegfilgrastim is approved to reduce the chance of infection in patients with:
- Neutropenia caused by myelosuppressive chemotherapy for certain types of cancer.
Pegfilgastrim is a form of filgrastim that has polyethylene glycol (PEG) attached to it. This form stays in the body longer than does filgrastim, so it doesn’t need to be given as often. For more information about filgrastim, see the Drug Information Summary for Filgrastim.
More About Pegfilgrastim
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
MedlinePlus Information on Pegfilgrastim - A lay language summary of important information about this drug that may include the following:
- warnings about this drug,
- what this drug is used for and how it is used,
- what you should tell your doctor before using this drug,
- what you should know about this drug before using it,
- other drugs that may interact with this drug, and
- possible side effects.
Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.
Research Results and Related Resources
Immune System Modulators
Clinical Trials Accepting Patients
Find Clinical Trials for Pegfilgrastim - Check for trials from NCI's list of cancer clinical trials now accepting patients.
Important: The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.
